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A Mutation in ZNF513, a Putative Regulator
of Photoreceptor Development,
Causes Autosomal-Recessive Retinitis Pigmentosa
Lin Li,1,4,9 Naoki Nakaya,2,9 Venkata R.M. Chavali,5,9 Zhiwei Ma,1 Xiaodong Jiao,1 Paul A. Sieving,3
Sheikh Riazuddin,6,7 Stanislav I. Tomarev,2 Radha Ayyagari,5,10 S. Amer Riazuddin,6,8,10
and J. Fielding Hejtmancik1,10,*
Retinitis pigmentosa (RP) is a phenotypically and genetically heterogeneous group of inherited retinal degenerations characterized clin-
ically by night blindness, progressive constriction of the visual fields, and loss of vision, and pathologically by progressive loss of rod and
then cone photoreceptors. Autosomal-recessive RP (arRP) in a consanguineous Pakistani family previously linked to chromosome
2p22.3-p24.1 is shown to result from a homozygous missense mutation (c.1015T>C [p.C339R]) in ZNF513, encoding a presumptive
transcription factor. znf513 is expressed in the retina, especially in the outer nuclear layer, inner nuclear layer, and photoreceptors.
Knockdown of znf513 in zebrafish reduces eye size, retinal thickness, and expression of rod and cone opsins and causes specific loss
of photoreceptors. These effects are rescued by coinjection with wild-type (WT) but not p.C339R-znf513 mRNA. Both normal and
p.C339R mutant ZNF513 proteins expressed in COS-7 cells localize to the nucleus. ChIP analysis shows that only the wild-type but
not the mutant ZNF513 binds to the Pax6, Sp4, Arr3, Irbp, and photoreceptor opsin promoters. These results suggest that the ZNF513
p.C339R mutation is responsible for RP in this family and that ZNF513 plays a key role in the regulation of photoreceptor-specific genes
in retinal development and photoreceptor maintenance.Results and Discussion
Retinitis pigmentosa (RP [MIM 268000]) refers to a group
of inherited retinal diseases with phenotypic and genetic
heterogeneity. The estimated worldwide prevalence of RP
is approximately 1 in 5000.
RP patients experience night blindness, followed by loss
of peripheral visual field and later loss of central vision,
often leading to complete blindness. RP initially affects
the rod photoreceptors; the function of the cone photore-
ceptors is compromised as the disease progresses.1 Affected
individuals often have severely abnormal or nondetectable
rod responses in the electroretinogram (ERG) recordings
even in the early stage of the disease.1 The classic symptom
of patients with RP is the subjective complaint of nycta-
lopia, defined as difficulty adapting or seeing in a dimly
lit environment. Nyctalopia is frequently present early in
the disease course of arRP (median age of onset is 11 years)
but occurs relatively later in association with autosomal-
dominant RP (median age of onset is 24 years).2 Classically,
RP has been classified based on the genetic inheritance
pattern: autosomal-dominant (about 30%–40% of cases),
autosomal-recessive (50%–60%), or X-linked (5%–15%).3–5
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Many of these can be grouped by function, giving insights
into the disease process. These include components of the
phototransduction cascade, proteins involved in retinol
metabolism, proteins involved in cell-cell interaction,
photoreceptor structural proteins, transcription factors,
intracellular transport proteins, and splicing factors.3,6–10
We previously mapped an arRP locus to a 12.31 cM
(13.35 Mb) interval on chromosome 2p22.3-p24.1 flanked
by D2S220 and D2S367 in a consanguineous Pakistani
family (PKRP115, 61115).11 Here we identify a p.C339R
mutation in ZNF513 as the cause of arRP in this family
and show that knockdown of ZNF513 protein levels in
zebrafish embryos causes defective retinal development
and photoreceptor loss. In addition, normal but not
p.C339R mutant ZNF513 binds to specific photoreceptor
promoters, suggesting that it acts through changing the
transcriptional control of genes involved in retinal devel-
opment and maintenance.
Clinical details of the arRP family were previously
described.11 IRB approval was obtained for this study from
the Centre of Excellence in Molecular Biology (CEMB)
(Lahore, Pakistan) and National Eye Institute (Bethesda,
MD, USA). The participating subjects gave informed
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Table 1. Two-Point LOD Scores of 2p22.3-p24.1 Fine Mapping Markers
Marker cM Mb 0 0.001 0.01 0.05 0.1 0.2 0.3 0.4 Zmax qmax
D2S149 34 14.31 -N 2.75 0.8 0.37 0.68 0.71 0.49 0.22 0.71 0.2
D2S2150 40.5 20.39 2.43 1.72 0.84 0.3 0.2 0.1 0 0.03 0.03 0.4
D2S220 42.7 20.95 0.85 0.13 0.73 1.2 1.21 0.92 0.52 0.17 1.23 0.08
D2S2221 44.1 23.07 2.89 2.88 2.83 2.57 2.26 1.63 1 0.41 2.89 0
D2S2247 46.9 27.15 3.24 3.23 3.18 2.92 2.59 1.91 1.24 0.59 3.24 0
ZNF513(1015C>T) 27.6 3.38 3.37 3.32 3.06 2.72 2.04 1.36 0.68 3.38 0
D2S223 45.8 28.19 2.89 2.88 2.83 2.58 2.26 1.61 0.98 0.38 2.89 0
D2S165 47.1 28.45 3.15 3.14 3.09 2.85 2.54 1.89 1.23 0.58 3.15 0
D2S2383 48.5 30.02 3.23 3.22 3.17 2.93 2.61 1.96 1.29 0.61 3.23 0
D2S2347 50.6 33.23 3.09 3.08 3.03 2.79 2.48 1.85 1.19 0.55 3.09 0
D2S367 55 34.29 -N 0.17 0.78 1.27 1.3 1.05 0.67 0.28 1.31 0.09Helsinki. Threemarkers (D2S2221,D2S2383, andD2S2347)
were selected for fine mapping from the Marshfield map.
Two-point linkage analyses were performed with the
FASTLINK version of MLINK from the LINKAGE program
package.12,13 arRP was analyzed as a fully penetrant trait
with an affected allele frequency of 0.000001. Marker allele
frequencies were estimated from 50 control chromosomes.
Finemapping (Table 1) confirms the 2p22.3-p24.1 locus but
was unable to refine the critical interval further. Flanking
recombinant events are seen at D2S367 distally in indi-
vidual 8 and lack of homozygosity is seen at D2S220 proxi-
mally (Figure 1A).
One hundred and forty seven genes in the linked region
of chromosome 2p22.3-p24.1 were identified with the
NCBI gene browser. Exons, including more than 100 bp of
flanking sequence, were screened with an ABI PRISM 3130
automated sequencer (Applied Biosystems) and analyzed
with Seqman software (Lasergene). Primer pairs for indi-
vidual exons were designed with the primer3 program.
A total of 33 genes in this regionwere sequenced, including
the zinc finger 513 gene (ZNF513, AAH40650), which
shows a homozygous missense mutation (c.1015T>C
[p.C339R]) in exon 4 in all affected individuals and cosegre-
gatingwith the disease (Figure 1C). This change is predicted
to be damaging via Polyphen,14 which gives a position-
specific independent count (PSIC) score difference of 3.17.
Themutation is not seen in 242 ethnicallymatched control
chromosomes, providing a power of more than 80% for
detecting a polymorphism with a 1% frequency, and
C339 is conserved in all species from Homo sapiens to
Danio rerio as ascertained by a bioinformatic search of
NCBI-Blast by means of human ZNF513 DNA and protein
and MegAlign (DNASTAR Lasergene, Madison, WI). The
entire region surrounding the mutation is relatively well
conserved, especially among mammals (Figure 1D). No
additional sequence changes were identified in ZNF513,
and changes identified in other genes were either known
SNPs or noncoding polymorphisms (data not shown).The AmericanAnalysis with PSORT algorithms predicts the presence of
two types of classical nuclear localization signals at the
N-terminal of ZNF513 (Figure 1B): PRRK (pattern 4) and
PRRKQSH (pattern 7).15 Further, PROSITE algorithms
detect the presence of three Cys2His2-type zinc finger
binding domain signatures starting at residue Cys208
(CPHCPFACSSLGNLRRHQRTH), Cys418 (CPLCPYACGN
LANLKRHGRIH), and Cys446 (CSLCNYSCNQSMNLKRH
MLRH). This bioinformatic analysis suggests that the
p.C339Rmutation in ZNF513 is located in a transcriptional
regulation or effector domain.16 We hypothesized that the
p.C339R mutation might modify the structure of the zinc
finger and, consequently, the binding and activation of
various target genes by ZNF513.
In order to check expression of Znf513 in various mouse
eye tissues, quantitative (q) RT-PCR was performed accord-
ing to previously published protocols,17,18 by means of the
forward primer 50-GCTCATCTGGATAACCTGAAACG-30
andreverseprimer50-GCTACACCGAAAAGGTTTGTCAC-30.
Although Znf513 is expressed in all tissues tested, ocular
expression is greatest in the retina and least in the lens
and cornea, in which expression also plateaus early
(Figure 2A). Retinal expression of Znf513 increases progres-
sively with age, beginning to level off between 180 and
300days, the highest age tested (Figure 2A). This expression
pattern suggests that Znf513 expression is important not
only for eye and retinal development but also for mainte-
nance of the adult retina.
In situ hybridization analysis was used to localize expres-
sion of ZNF513 mRNA in the human retina. ZNF513 RNA
probes were generated from a ZNF513 cDNA clone in the
pOTB7 vector. The pOTB7-ZNF513 construct was linear-
ized with ClaI. SP6 and T7 RNA polymerases were used to
create sense and antisense digoxigenin (DIG)-labeled
RNA probes, respectively, from the linearized DNA. In
situ hybridization was performed on 7 mm cryosections
from the posterior segment of human eyes according to
previously published protocols.19,20 In situ hybridizationJournal of Human Genetics 87, 400–409, September 10, 2010 401
Figure 1. ZNF513 Region, Pedigree, Gene, and Sequence
(A) Haplotypes of the ZNF513 region of family 61115 showing the ZNF513 p.C339R mutation and surrounding microsatellite markers
included in Table 1. The risk haplotype is shown in black.
(B) Diagram of the ZNF513 gene showing the two nuclear localization signals (NLS), the p.C339R mutation, and the three zinc finger
binding domains (ZF) with their positions.
(C) Electropherograms show the affected sequence (left, individual 8), carrier sequence (middle, individual 12), and normal control
sequence (right) surrounding the ZNF513 1015T>C mutation.
(D) Amino acid sequence alignment around the ZNF513 C339 amino acid (red) in 31 species ranging from human to zebrafish.of ZNF513 shows expression in human retinal layers
including the outer nuclear layer (ONL), inner nuclear
layer (INL), and ganglion cell layer (GCL) (Figure 2B),
consistent with a potential role for the mutant in retinal
degeneration.
znf513 mRNA is expressed in early developing zebrafish
embryo brain and eyes according to the zebrafish model
database, suggesting that zebrafish might be a reasonable
model system to evaluate the role of znf513 in eye develop-
ment and function. An antisense morpholino oligonucleo-
tide (znf513-MO,50-GATTCTGCTGTTTTCTTCTTGGCAT-30)
targeting the znf513 translation initiation site and a402 The American Journal of Human Genetics 87, 400–409, Septembmismatch control morpholino (MM-MO, 50-GATTGTCC
TCTTTTCTTGTTCGCAT-30) were dissolved in distilled
water, mixed with 2X injection buffer, and injected into
egg yolks of 1- to 4-cell stage zebrafish embryos in order to
investigate wild-type and p.C339R znf513 expression and
function.Wild-type zebrafishweremaintained as described
by Westerfield,21 and embryos were produced by natural
matings. All experiments with animals were approved by
the NEI Animal Use and Care Committee.
Morpholino-sensitive EGFP was constructed by adding
the sequence 50-ATGCCAAGAAGAAAACAGCAGAATC-30
to the 50-end of EGFP cDNA and cloning into theer 10, 2010
Figure 2. Relative Expression of Znf513 in Mouse Eye Tissues at Various Ages and Distribution of ZNF513mRNA in the Human Adult
Retina
(A) Expression of Znf513 (Zpf513) was measured in lens, ciliary body (CB), iris, cornea, optic nerve, retina, and RPE tissues by qRT-PCR at
different time points during aging. Data represent the mean (5SD) on an arbitrary scale (y axis) representing expression relative to the
housekeeping gene Rpl19 and were calculated from at least three independent experiments. The inset shows the expression pattern of
Znf513 in the post natal-stage eye from P1 to P30.
(B) In situ hybridization of ZNF513 probes in the retina of human eyes at 55C–69C. Hybridizationwith the antisense probe (left) shows
signal (black arrows) in the ONL, INL, and GCL when contrasted to hybridization with the sense probe (right). Counter stain is nuclear
fast red. RPE, retinal pigmented epithelia; OS, outer segment; ONL, outer nuclear layer; INL, inner nuclear layer; OPL, outer plexiform
layer; IPL inner plexiform layer; GCL, ganglion cell layer.pCS2þ vector, as was unmodified EGFP cDNA. To test
morpholino inhibitory activity, EGFP mRNA fused to the
morpholino-sensitive sequence at the 50-end (50-modified
EGFP) was injected prior to morpholino injections. High-
intensity EGFP fluorescence is observed in 50-modified
EGFP mRNA-injected embryos and eliminated by znf513-
MO injection (Figures 3A and 3B). znf513-MO injection
does not reduce expression of native EGFP without the
morpholino-sensitive sequence, and MM-MO injection
has no effect on expression of 50-modified EGFP (Figures
3C and 3D), consistent with the ability of the morpholino
to inhibit expression of znf513 specifically.
Zebrafish embryos treated with the znf513-MO show
normal development until 24 hr postfertilization (hpf).
After 37 hpf, znf513-MO treatment (Figures 3F and 3I)
causes a reduction in eye size not seen in larvae treated
with MM-MO (Figures 3G and 3H) or buffer (Figure 3E).
The eye size phenotype induced by znf513-MO is partially
rescued with coinjection of WT but not p.C339R zebrafish
znf513 mRNA. Injection of the znf513-MO results in
89% of fish with an abnormal phenotype and only 11%
with a normal phenotype. For rescue, the full-length
cDNA (Open Biosystems) was subcloned into the pCS2þ
vector. znf513 RNA was synthesized with a mMESSAGE
mMACHINE kit (Ambion). Synthesized RNAs were in-
jected into 1-cell stage embryos with/without indicated
MOs. Rescue of the normal phenotype is almost complete
with coinjected WT mRNA, giving 86% of fish with
a normal phenotype as compared to coinjection withThe Americanp.C339R znf513 mRNA, which gave only 31% of fish
with a normal phenotype. This suggests that the effect is
specifically caused by knockdown of endogenous znf513
protein (Figure 3J) and that the p.C339R mutation inhibits
znf513 protein function.
Immunofluorescence studies show that znf513-MO
injection preferentially affects specific retinal layers. Fixed
zebrafish embryos were equilibrated in 20% sucrose and
embedded in OCT (Electron Microscopy Sciences). Frozen
sections (10 mm) were produced with a cryostat (CM3050,
Leica Microsystems). Sections were blocked with 1%
normal goat serum/1% BSA and incubated with anti-
PKCb1 (1:300, Santa Cruz), Zpr-1 (1:200, Zebrafish Interna-
tional Resource Center), 1D1 (1:50),22 1D4 (1:1000), and
rabbit anti-opsin (anti-blue, 1:250; anti-green, 1:500;
anti-red, 1:500; anti-UV, 1:1000).23 Slides were washed in
PBS and incubated with Alexa488- or Alexa595-conjugated
goat anti-mouse or anti-rabbit IgG (1:400, Invitrogen) and
with DAPI for nuclear staining. Images were collected with
Axioplan 2 and LSM 700 confocal microscope (Carl Zeiss).
The thickness of retinal layers and the number of cells were
measured with ImageJ software. The inner plexiform layer
(IPL), INL, GCL, and ONL of znf513-MO-treated larvae
(Figures 4A and 4B versus Figures 4C and 4D) are much
thinner in the znf513-MO-treated than MM-MO-treated
larvae (see also Figure 4M, p < 0.05). The znf513-MO-
treated larvae also show reduced staining for rod photore-
ceptors markers. By 5 dpf, rod photoreceptor cells are
almost completely absent from the retina and are observedJournal of Human Genetics 87, 400–409, September 10, 2010 403
Figure 3. Zebrafish Eye Development Disturbed by Knockdown of znf513 Expression and Rescue of znf513 Morphants
Morpholino-sensitive 50-modified EGFPmRNA (A, B, C) or native unmodified EGFP (D) was injected to single cell stage embryos. znf513-
MO (B, D, F, I), MM-MO (C, G, H), or injection buffer (E) was injected into embryos.
(A–D) Validation of the activity of znf513-MO on the expression of znf513. znf513-MO injection eliminated the fluorescence signal
(green on the embryo body, arrowheads) from coinjected morpholino-sensitive 50-modified EGFP mRNA (B), and it did not reduce
the expression of native unmodified EGFPwithout the znf513 sequence (D). MM-MOhad no effect onmorpholino-sensitive GFP expres-
sion (C). Note that all embryos contain faint yellowish autofluorescence in the egg yolk not derived from EGFP.
(E–G) 0.5 ng Znf513-MO (F) dramatically reduced eye size (black arrows) compared to MM-MO-injected (G) and buffer-injected (E)
embryos.
(H and I) Higher magnification of the heads from embryos shown in (G) and (F) showing reduced size of the retina in a znf513-MO-
injected embryo relative to a MM-MO-injected embryo (l, lens; r, retina, white arrows).
(J) Graph depicting proportions of embryos with abnormal phenotype (eye size) associated with znf513-MO injection and rescue by
coinjected znf513 mut and WT mRNA.
(A–D) 24 hpf, (E–I) 37 hpf. Scale bars represent 1 mm in (A)–(G) and 100 mm in (H) and (I).only at the retinal margin, a region of persistent neurogen-
esis in teleost fish (Figure 4D). Even at the margin, rod cells
often have an abnormal morphology or are pyknotic, sug-
gesting that these rods might be directed to cell death.
Cone opsin staining in znf513-MO-treated larvae (Figures
4F, 4H, and 4L) decreased compared to MM-MO-treated
larvae (Figures 4E, 4G, and 4K), while rhodopsin (Figures
4F, 4H, 4J, and 4L) and red opsin (Figure 4J) signals are
completely absent from znf513-MO-treated larvae. Reduc-
tion of the green opsin and elimination of the red opsin in
MO-treated retina suggests that remaining green/red cones
are dysfunctional cone bodies (Figure 4C).
Wild-type and mutant human GFP-ZNF513 fusion
proteins were analyzed by western blotting after transient
transfection of COS-7 cells with wild-type and mutant
GFP-ZNF513 constructs. The cells were harvested 48 hr
after transfection, and western blot analysis was performed
with 30 mg reduced proteins separated on 10% Bis-Tris gels
(Invitrogen). Wild-type and mutant GFP-ZNF513 proteins
are expressed with an approximate molecular weight of
82 kDa (Figure 5A), consistent with the expectedmolecular
mass.
In order to localize the human ZNF513 protein within
the cell, COS-7 cells were transfected with expression
constructs via Fugene 6 HD transfection reagent (Roche).404 The American Journal of Human Genetics 87, 400–409, SeptembFixed cells were incubated with primary antibody: C23
(H-6) mouse monoclonal antibody (1:1000 dilution, Santa
Cruz) and GFP mouse monoclonal antibody (Santa Cruz)
followed by washing with PBS and incubation with the
secondary antibody. Subsequently, washed cells were
mounted with Vectashield anti-fade mounting medium
containing DAPI.24 Immunofluorescence was visualized
with a Zeiss LSM 510 laser scanning confocal microscope.
Both the wild-type and p.C339R mutant GFP-ZNF513
proteins localize indistinguishably as dispersed foci in the
nucleus but not with the nucleolus as indicated by lack of
overlap with the nucleolin fluorescence (Figures 5B–5I).
This is consistent with a possible role for ZNF513 as a
transcriptional regulator and suggests that the p.C339R
mutation does not affect nuclear localization and of the
ZNF513 protein.
The mechanism through which the p.C339R ZNF513
mutant acts was further investigated by expression and
chromatin immunoprecipitation (ChIP) studies. ChIP
assay was performed as per the manufacturer’s instructions
(ActiveMotif) withmodifications in washing conditions to
minimize high background and nonspecific reactions. NIH
3T3 cells were transfected with the wild-type human
GFP-ZNF513 and mutant GFP-ZNF513 plasmids with Fu-
gene HD transfection reagent (Roche) as described above.er 10, 2010
Figure 4. Inhibition of Cone and Rod Photoreceptor
Development by Knockdown of znf513 Gene Expres-
sion
(A–D) Merged photos of frozen sections from MM-MO-
injected (A, B) and znf513-MO-injected (C, D) zebrafish
embryos stained for PKCb1 (bipolar cells, green), Zpr-1
(cone photoreceptors, red, A and C), 1D1 (rod receptors,
red, B and D), and DAPI (nuclei, blue). znf513-MO-
injected embryos show decreased thickness of all layers
except the OPL.
(E–L) Staining of znf513-MO- and MM-MO-injected
embryos for specific opsins. Frozen sections from MM-
MO-injected (E, G, I, K) and znf513-MO-injected (F, H,
J, L) embryos were stained with anti-blue opsin (E, F,
green), anti-green opsin (G, H, green), anti-red opsin
(I, J, green), anti-UV opsin (K, L, green), 1D4 (all,
Rhodopsin, red), and DAPI (all, nuclei, blue). There is a
decrease in each opsin in znf513-MO-injected embryos,
with rhodopsin and red opsin being essentially absent.
(M) Comparison of retina layer thicknesses in mm, eye
perimeter, and cell number between the znf513-MO-
treated (n ¼ 5) and MM-MO-treated (n ¼ 7) larvae. t is
the unpaired Student’s t test statistic. IN, inner nuclear
layer cells. p<0.05was considered statistically significant.
(A–L) 5 dpf. Scale bars represent 50 mm in (A)–(D) and
15 mm in (E)–(L). ONL, outer nuclear layer; INL, inner
nuclear layer; IPL, inner plexiform layer; GCL ganglion
cell layer.The cells grown in a 10 cm plate were treated with formal-
dehyde at a final concentration of 1% for 10 min at room
temperature (RT). The reaction was quenched with the
addition of glycine to a final concentration of 125 mM.
1 ml of cold 13 PBS supplemented with PMSF was addedFigure 5. Characterization of Mutant and Wild-Type GFP-ZNF513 Proteins
in COS-7 Cells by Immunofluorescence
(A) Blot of COS-7 cell lysates probed with GFP antibodies. Lane 1, untransfected
lane 3, lysate transfected with mutant ZNF513-GFP; lane M, SeeBlue2 Plus m
migrate at the predicted MW of 82 kDa.
(B–I) COS-7 cells were transfected with pEGFPC1 fused in-framewith wild-type (
nostained with C23 antibody (red, nucleolus) or DAPI (40,6-diamidino-2-pheny
three columns are shown in (E) and (I). Scale bars represent 10 mm. Both wil
nucleus in a speckled pattern.
The American Journal of Hto each plate and the cells were scrapped with
a rubber policeman. The cell pellet was collected
by centrifugation and resuspended in 1 ml of ice
cold 13 PBS supplemented with protease inhib-itor cocktail (PIC) (Sigma) and incubated on ice for 30
min. To aid nuclei release, the cell suspension was stroked
for at least 10 times with a Dounce homogenizer and then
centrifuged at 5000 rpm for 10 min to pellet the nuclei.
The nuclei pellet was resuspended in digestion buffer andby Western Blot Analysis and Localization of ZNF513
lysate; lane 2, transfected wild-type ZNF513-GFP lysate;
olecular weight marker. Both WT and mutant proteins
B–E) or p.C339Rmutant (F–I) ZNF513. Cells were immu-
lindole, blue, nucleus). Overlays of images from the first
d-type (WT) and mutant (Mut) proteins localize to the
uman Genetics 87, 400–409, September 10, 2010 405
Figure 6. Chromatin Binding and ChIP Analysis of ZNF513
(A) Agarose gel electrophoresis with the chromatin from NIH 3T3
cells transfected with wild-type GFP-ZNF513.
(B) The DNA binding proteins present in the immunoprecipitated
chromatin analyzed by western blotting via GFP antibody.
(C) ChIP assays with NIH 3T3 cells transfected with wild-type GFP-
ZNF513 (left) or p.C339R mutant GFP-ZNF513 (right) with GFP
monoclonal antibody (þAb). Normal rabbit IgG (–Ab) and no
chromatin (Mock) samples serve as negative controls, whereas
input (chromatin samples without IP) serve as positive controls.
Arr3, cone arrestin; Rho 50, rhodopsin 50 regulatory region; IER,
enhancer of interphotoreceptor retinoid binding protein (IRBP);
Rho30, exonic 30 region of Rhodopsin; Nr2e3, nuclear receptor
subfamily 2, group E, member 3; Nrl, neural retina leucine zipper;
Sp4, Sp4 transcription factor; Pax2, paired box gene 2; Mop,
M-cone opsin; Sop, S-cone opsin; Pax6, paired box gene 6. Specific
bands are seen for Arr3, Rho50, IER, Sp4, Mop, Sop, and Pax6 with
the wild-type but not the p.C339R mutant GFP-ZNF513.enzymatic shearing cocktail and incubated at 37C for
10 min with intermittent vortexing to ensure that the
chromatin was evenly sheared. The reaction was stopped
with ice-cold 0.5 M EDTA and chilled on ice for 10 min.
The sheared chromatin was centrifuged at 15,000 rpm at
4C for 10 min, and the supernatant containing the
sheared chromatin was collected. Agarose gel electropho-
resis via the chromatin from NIH 3T3 cells transfected
with wild-type GFP-ZNF513 is shown in Figure 6A. Lane
1 shows the pulldown chromatin fraction bound to
ZNF513 by the GFP antibody as a faint smear, which is
absent in lane 2 that shows the fraction immunoprecipi-
tated with normal serum IgG. The input DNA is shown
in lane 3 as a dense smear. These data suggest that a
small subset of sheared DNA is bound by the ZNF513
protein, consistentwith its putative role as a transcriptional
regulator.
The presence of ZNF513 protein in both the input and
the immunoprecipitated fractions was tested by western
blot analysis with GFP monoclonal antibody. An immuno-
precipitation reaction was set up with 25 ml protein G406 The American Journal of Human Genetics 87, 400–409, Septembmagnetic beads, 20 ml ChIP buffer 1 (a proprietary compo-
nent of the Active Motif ChIP-IT Express magnetic chro-
matin immunoprecipitation kit, Carlsbad, CA), 100 ml
sheared chromatin, 1 ml PIC, dH2O, 2 mg of monoclonal
GFP antibody (Clontech, Mountain View, CA) and incu-
bated overnight at 4C. The magnetic beads were pelleted
on a magnetic stand and the supernatant was discarded.
The beads were washed with three volumes of ChIP Buffer
1, two volumes with high salt buffer (20 mM Tris-Cl, 1 mM
EDTA, 0.1% SDS, 1% Triton X-100, 500 mM NaCl
[pH 7.4]), and three volumes of ChIP Buffer 2 (a proprietary
component of the Actve Motif ChIP-IT Express magnetic
chromatin immunoprecipitation kit, Carlsbad, CA). The
bound chromatin was eluted from the beads by incubating
the beads in 50 ml of elution buffer AM2 for 20 min at RT
on an end to end rocker. Reverse cross-linking buffer
was added to eluted chromatin and the magnetic beads
were pelleted with a magnetic stand. The supernatant
containing the chromatin bound to the antibody was
incubated at 65C for 3 hr and treated with RNAase A
and Proteinase K before precipitating it with 3M sodium
acetate (pH 5.2) and ethanol. Western blot analysis reveals
the presence of GFP-ZNF513 protein in the total chromatin
fraction (Input) and in the pulldown fraction with GFP
antibody (ZNF513-GFP, 82 KDa, Figure 6B). No bands are
seen after immunoprecipitation with normal IgG (Mock).
Both immunoprecipitation and western analysis indicate
the ability of ZNF513 to bind DNA.
Interaction of ZNF513 with the promoters of other tran-
scription factors (TFs) known to play a role in the develop-
ment and maintenance of photoreceptor genes and their
targets was investigated by examining ZNF513 binding to
chromatin isolated from NIH 3T3 cells transfected with
either wild-type GFP-ZNF513 or mutant GFP-ZNF513
plasmids. Chromatin immunoprecipitated with antibodies
to GFP was tested for the presence of known photoreceptor
gene promoters by PCR analysis with specific primers via
1.5% agarose gels.25,26 The Pax6 (MIM 607108), Pax2
(MIM 167409), and Sp4 (MIM 600540) promoters and
those of their targets including Arr3 (MIM 301770, cone
arrestin), Rhodopsin (MIM 180380, 50 regulatory region
and 30 exon region), IRBP (MIM 180290, interphotorecep-
tor Retinoid Binding Protein), IER (IRBP enhancer region),
Nr2e3 (MIM604485, nuclear receptor subfamily 2, group E,
member 3), Nrl (MIM 162080, neural retina leucine
zipper), Mop (Opn1m2, MIM 303800, M-cone opsin), and
Sop (OPN1SW, MIM 190900, S-cone opsin) were tested.
Only wild-type ZNF513 is found to be associated with the
proximal promoter regions of Pax6 and Sp4 (Figure 6C)
and their known targets including Arr3, Rhodopsin, Mop,
Sop, and IER. PCR amplification for the minus antibody
or minus input DNA controls is negative as are negative
controls with normal rabbit IgG. The mutant ZNF513
shows no interaction with the above genes, indicating
that the p.C339R mutation disrupts the binding site in
ZNF513 necessary for interaction with the specific targets
mentioned above (Figure 6C).er 10, 2010
Here, we have identified a homozygous missense muta-
tion in the ZNF513 gene in affectedmembers of a Pakistani
family with arRP. These data strongly implicate the
p.C339R mutation in ZNF513 with RP. ZNF513 is highly
expressed in the retina, and both the failure of the
p.C339R mutant znf513 to rescue the zebrafish phenotype
and the failure of the mutant protein to bind to the
promoters of retinal-specific genes argue for its pathoge-
nicity. Knockdown of znf513 in zebrafish causes abnormal
retinal development with major effects on photoreceptors,
including retinal thinning with photoreceptor degenera-
tion and decreased numbers. That ZNF513 binds to the
promoters of a variety of retinal transcription factors and
their known targets suggest that it acts through transcrip-
tional regulation. Taken together, these results suggest
that ZNF513 has an important role in the early retinal
development and later in maintenance. They also show
that inhibition of ZNF513 expression causes structural
and functional defects in the retina, consistent with the
clinical and pathologic findings in human eyes with RP.
Although little is currently understood about the physi-
ological functions of ZNF513, it is a widely expressed zinc
finger DNA binding protein with a potential role in regu-
lating the transcription of specific genes in the retina.
Rod and cone photoreceptors in vertebrate retina are
regulated by a network of photoreceptor transcription
factors. Some of these factors regulate expression of them-
selves by binding to their own promoters, or regulate other
factors acting in parallel or downstream. A few of these
factors also act synergistically.27 ChIP analysis reveals that
ZNF513 interacts with the Sp4, IER, Rho, Arr3, M-cone
opsin, S-cone Opsin, and Pax628,29 promoters whereas no
interaction is observed with transcription factors Nrl,
Nr2e3, and Pax2. Both Nrl30 and especially Nr2e3 can
repress the transcription of cone-specific genes and acti-
vate rod-specific genes. Crx, a key regulator of photore-
ceptor transcription, regulates rod opsin expression syner-
gistically with Nrl. In addition, Sp4, a widely expressed
protein, also activates transcription from the rod opsin
promoter synergistically with Crx. Sp4 could have a more
universal role in cell type-specific expression of certain
genes in rods and possibly other retinal cell populations
by interacting with different arrays of transcription
factors.31 Although ZNF513 does not interact directly
with Nrl and Nr2e3, which are primarily involved in
the regulation of rod cell development, it shows strong
interaction with the promoter sequences of rhodopsin,
IER, and Sp4.
Regulation of cone photoreceptor development is much
more complex than that of rods. Extrinsic factors such as
retinoic acid, thyroid hormone, and other positive and
negative regulators of cone-specific gene expression have
been implicated in development and maintenance of
cones.27 These regulators bind to cone-specific gene pro-
moter sequences including the human locus control
region (LCR) of red and green opsin genes and participate
in regulation of expression of these genes, cone cell devel-The Americanopment, and distribution. ChIP assays show that ZNF513
can directly bind to the promoters of cone genes, including
cone arrestin (Arr3), IRBP, Mop, and Sop. Structurally, the
putative ZNF513 protein contains a nuclear localization
signal in addition to zinc finger domains. Transient expres-
sion of ZNF513 shows localization of this protein to the
nucleus. Therefore, the nuclear protein ZNF513, which
binds to Sop and Mop promoter sequences, could be
a new member of the factors that regulate the expression
of opsins and participate in regulation of cone cell develop-
ment and function. These observations in combination
with retinal abnormalities observed in zebrafish knock-
down model suggest a role for ZNF513 in regulation of
photoreceptor gene expression in the retina.
In contrast to the wild-type protein, the mutant ZNF513
protein does not bind the Sp4, Arr3, Irbp, Rho, Mop, or Sop
promoters, suggesting that p.C339 is located in a domain
essential for recognition of specific sites for these genes.
This is consistent with a role for ZNF513 as a common
regulator of photoreceptor-specific gene expression within
the combinatorial model of transcriptional regulation of
cell-specific gene expression.
During early development of the eye, Pax6 plays a critical
role in retinal cell fate and oculogenesis. Defects in Pax6
expression are involved in several abnormalities, including
aniridia and Peter’s anomaly in humans and the small eye
syndrome in mice.32 Photoreceptors may initially require
expression of Pax6 to regulate their proliferation, and
disappearance of this expression precedes the onset of
their differentiation.33 Lack of interaction of the mutant
ZNF513 with the Pax6 promoter sequence and smaller
size of the eyes in morpholino-injected zebrafish suggests
a role for ZNF513 in eye development that is potentially
mediated through its interaction with the Pax6 promoter.
Although ZNF513 is expressed broadly throughout the
body including white blood cells, bladder, brain, parathy-
roid gland, ovary, and testis, affected individuals in this
family have isolated RP without any systemic signs or
symptoms. The reason for the retinal specificity of the
phenotype is not clear, but suggests that the p.C339R
mutation might possibly retain some activity for genes
important in nonocular tissues. The retinal phenotype of
patients from the Pakistani family with the p.C339R
mutation in ZNF513 include significantly diminished rod
and cone responses, macular atrophywith pigment clump-
ing, and peripheral retinal abnormalities, suggesting
the involvement of both rod and cone photoreceptors
in the disease pathology.11 It is unclear at present why
individuals with this mutation do not have a more
severe or early-onset retinal disease, although it is possible
that this might also relate to some residual activity in
the p.C339R mutant protein. ZNF513 may influence the
terminal differentiation and maintenance of photorecep-
tors through interactions with both a network of retinal
transcription factors and retinal-specific functional genes.
These observations strongly suggest that the p.C339R
mutation interferes with retinal development andJournal of Human Genetics 87, 400–409, September 10, 2010 407
photoreceptor survival through disruption of the specific
binding of ZNF513 to a subset of these genes. Interaction
of ZNF513 with members of the photoreceptor transcrip-
tional network may involve protein-protein or protein-
promoter interactions or both. Understanding these inter-
actions and the role of ZNF513 in the retina may assist in
unraveling the mechanism underlying retinal degenera-
tion because of mutant ZNF513.Supplemental Data
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